18 Stocks in focus today

Check out the companies which will be in focus during trade today based on recent and latest news developments.

HDFC Bank: The bank is planning to add 100 branches in the eastern region, taking its total tally to 600 branches by the end of ongoing financial year.

Reliance Industries: The company has successfully tested presence of natural gas in one of the two KG-D6 block natural gas discoveries which the sector regulator DGH had previously refused to recognise.

Aurobindo Pharma: The pharma company has received final approval from US health regulator to make and sell in America the generic Telmisartan tablets used for treating hypertension.

PVR Ltd: The company has approved an amalgamation scheme between Bijli Holdings Pvt Ltd and itself to simplify PVR's shareholding structure.

IndusInd Bank: RBI has removed IndusInd Bank from its caution list, allowing foreign investors to buy further shares in the lender.

Maruti Suzuki: The company is planning to advance production from its Gujarat facility by three to six months. The company may begin production from Gujarat in January 2017.

Suzlon Energy: The board of the company has sought shareholders' approval to raise up to Rs. 50 billion through the issue of securities.

Rajesh Exports Ltd: The company has bagged an export order worth Rs. 1,123 crore from Singapore for gold and diamond studded jewellery.

Amara Raja Batteries: The company plans to commission the tubular battery plant at Nunegundlapalli in the Chittoor district of Andhra Pradesh by December 2015, Vice-Chairman and MD Jaydev Galla told shareholders.

IL&FS Transportation Networks Ltd: ITNL is reportedly looking to sell most of its operational annuity road projects in a bid to pare debt before the end of FY16. The company is in early-stage talks with international pension funds, besides domestic and foreign private equity (PE) firms, according to a financial daily.

Vijaya Bank: The Bank has approved the reduction of Base Rate by 15bps from 10% p.a. to 9.85% p.a. with effect from September 04, 2015.

Glenmark Pharmaceuticals: The pharma company said it has received final approval from the US health regulator for Voriconazole Tablets, used to treat fungal infections.

Wockhardt: The pharma company continue to strengthen its R&D capabilities to develop innovative and technologically advanced medicines. The firm has set up three world-class, multi-disciplinary R&D facilities in India, the UK and the US, which are engaged in studies and experiments to develop new drugs and novel drug delivery systems.

Aditya Birla Nuvo Ltd: The Aditya Birla Nuvo approved termination of plans to issue GDRs by group firm Pantaloons Fashion and Retail (PFRL) as envisaged under a merger scheme to consolidate their branded apparel business due to regulatory issues.

Srei Infra, Tata Teleservices: American Tower Corp. (ATC) is reportedly planning to acquire a majority stake in tower rival Viom Networks that will see the Tata group retain a minority stake. Tata Teleservices has 54% stake in Viom and Srei owns 18.5% while the rest is held by private equity firms Macquarie SBI Infrastructure, GIC Investments, IDFC Private Equity and Funderburk Mauritius (Oman Investment, says report.

Dr Reddy's Laboratories Ltd: The company is recalling over 55,000 bottles of Amlodipine besylate and Atorvastatin calcium tablets, used to treat high blood pressure and cholesterol related diseases, in the US market.

Natco Pharma Ltd: The Reserve Bank of India has notified that Foreign Institutional Investors (FIIs)/Registered Foreign Portfolios Investors (RFPIs) can now invest up to 31.50 per cent of the paid up capital of M/s Natco Pharma Limited under the Portfolio Investment Scheme (PIS).

ONGC: ONGC Videsh will acquire a 15% stake in the Vankor oil field of Russian state firm Rosneft for about $1.35 billion (Rs. 8,910 crore), as per media reports.